Laurion Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-171,887
| Closed | -$2.37M | – | 268 |
|
|
2024
Q2 | $2.37M | Buy |
171,887
+6,904
| +4% | +$95.1K | 0.03% | 108 |
|
|
2024
Q1 | $2.73M | Hold |
164,983
| – | – | 0.02% | 159 |
|
|
2023
Q4 | $2.41M | Buy |
+164,983
| New | +$2.41M | 0.02% | 101 |
|
|
2023
Q3 | – | Sell |
-10,134
| Closed | -$121K | – | 278 |
|
|
2023
Q2 | $121K | Sell |
10,134
-4,866
| -32% | -$58.1K | ﹤0.01% | 274 |
|
|
2023
Q1 | $201K | Hold |
15,000
| – | – | ﹤0.01% | 207 |
|
|
2022
Q4 | $323K | Buy |
15,000
+763
| +5% | +$16.4K | ﹤0.01% | 166 |
|
|
2022
Q3 | $285K | Sell |
14,237
-763
| -5% | -$15.3K | ﹤0.01% | 213 |
|
|
2022
Q2 | $269K | Sell |
15,000
-76,239
| -84% | -$1.37M | ﹤0.01% | 259 |
|
|
2022
Q1 | $905K | Buy |
+91,239
| New | +$905K | 0.01% | 147 |
|